DEGENERATION OF DOPAMINERGIC PATHWAYS
多巴胺能通路的退化
基本信息
- 批准号:6098265
- 负责人:
- 金额:$ 21.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-06-01 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer's disease Lewy body Parkinson's disease antireceptor antibody autoradiography brain disorder diagnosis brain mapping cell death dopamine dopamine receptor extrapyramidal disorder genetically modified animals histochemistry /cytochemistry histopathology human tissue immunocytochemistry laboratory mouse mesencephalon messenger RNA molecular pathology neural degeneration neurofilament
项目摘要
Midbrain dopamine (DA) neurons are susceptible to premature death in both
PD and AD, but different populations of neurons are affected. As these
populations of neurons provide input to different territories within the
striatum there are different patterns of DA loss in the striatum. It is
evident that different processes must be involved as LBs do not typically
exist in midbrain neurons of AD cases. A significant proportion of AD
cases also develop of extrapyramidal symptoms that closely resemble
Parkinsonism in PD cases. It has been assumed that they must represent
a combination of the two diseases (AD plus PD). However, it is also
evident that AD patients developing extrapyramidal symptoms do not show
the typical pathology of PD (i.e., accumulation of LBs and cell loss in
the substantia nigra), yet show losses of DA transporter sites (DAT)
associated with DA terminals within the striatum. Midbrain DA neurons
show a complex organization of subgroups of neurons which can be
differentiated into different populations based on morphological
criteria, neuromelanin content, tyrosine hydroxylase (TH) content, DAT
levels, DAT mRNA levels, TH mRNA levels, co-localized neuropeptides and
their innervation by different striatonigral afferents. Finally, these
populations of neurons provide input to different territories within the
striatum and are affected in normal aging, PD and AD in distinctly
different ways. Thus, it is unclear what role LBs play in either the
vulnerability of midbrain DA neurons to premature death or in the
neuronal disturbances within those neurons (e.g., reduced TH protein and
TH mRNA). It has also not been identified how the biochemical
heterogeneity of the different populations of midbrain DA neurons are
related to these same processes.
For these reasons this project is designed to characterize how LBs affect
midbrain DA neurons by analysis of PD material with radioligand
autoradiography, immunoautoradiography and in situ hybridization
histochemistry for a variety of proteins and their mRNAs that are
characteristic of midbrain DA neurons. Second characterize the age
related biological consequences of the progressive accumulation of NF-
rich LB-like lesion in midbrain DA neurons of transgenic mice engineered
to express a NFH/LacZ fusion protein that causes aggregation of NF into
inclusions in neuronal perkarrya. Third, identify if the biochemical
heterogeneity of the different populations of midbrain DA neurons is
related to neuronal vulnerability in AD and AD with Parkinsonism, since
these diseases differ markedly in their susceptibility to DA neuron loss
and pathogenesis to DA terminals. Fourth, determine by receptor
autoradiography and in situ hybridization histochemistry if the target
receptors (for members of the D2 receptor family) of these different
populations of midbrain DA neurons are selectively affected in AD, PD and
AD with Parkinsonism.
中脑多巴胺(DA)神经元在两者中都易于过早死亡
PD和AD,但神经元的不同种群受到影响。 这样
神经元的种群向内部的不同地区提供了输入
纹状体中有不同的DA损失模式。 这是
显然,必须涉及不同的过程,因为LB通常不会
存在于AD病例的中脑神经元中。 广告中很大一部分
病例还会发展出非常相似的腹膜外症状
PD案例中的帕金森氏症。 已经假定他们必须代表
两种疾病的组合(AD加PD)。 但是,也是
显然,出现腹膜外症状的AD患者未显示
PD的典型病理(即,LBS的积累和细胞损失
底底),但显示了DA运输站点的损失(DAT)
与纹状体内的DA末端相关。 中脑DA神经元
显示一个复杂的神经元亚组的组织
基于形态学分为不同的人群
标准,神经苯胺含量,酪氨酸羟化酶(Th)含量,DAT
水平,DAT mRNA水平,TH mRNA水平,共定位的神经肽和
它们由不同的纹状体传入。 最后,这些
神经元的种群向内部的不同地区提供了输入
纹状体,在正常衰老,PD和AD中受到影响
不同的方式。 因此,尚不清楚lbs在任何一个中的作用
中脑da神经元的脆弱性过早死亡或
这些神经元内的神经元障碍(例如,TH蛋白质降低和
th mRNA)。 还没有确定生化如何
中脑DA神经元不同种群的异质性是
与这些相同的过程有关。
由于这些原因,该项目旨在表征LB的影响
通过分析具有放射性的PD材料的中脑DA神经元
放射自显影,免疫摄影和原位杂交
各种蛋白质及其mRNA的组织化学
中脑DA神经元的特征。 第二个年龄的特征
NF-进行性积累的相关生物学后果
转基因小鼠的中脑DA神经元中的丰富LB样病变。
表达NFH/LACZ融合蛋白,该蛋白会导致NF聚集到
神经元中的夹杂物。 第三,确定是否生化
中脑DA神经元不同种群的异质性是
与帕金森氏症的AD和广告中的神经元脆弱性有关,因为
这些疾病在对DA神经元丧失的敏感性方面明显不同
DA末端的发病机理。 第四,通过受体确定
放射自显影和原位杂交组织化学
这些不同的受体(对于D2受体家族的成员)
中脑DA神经元的种群在AD,PD和
广告帕金森主义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY N JOYCE其他文献
JEFFREY N JOYCE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY N JOYCE', 18)}}的其他基金
MESOLIMBIC DOPAMINE D3 RECEPTOR AND PARKINSON'S DISEASE
中脑边缘多巴胺 D3 受体与帕金森病
- 批准号:
6454935 - 财政年份:2000
- 资助金额:
$ 21.7万 - 项目类别:
MESOLIMBIC DOPAMINE D3 RECEPTOR AND PARKINSON'S DISEASE
中脑边缘多巴胺 D3 受体与帕金森病
- 批准号:
6394298 - 财政年份:2000
- 资助金额:
$ 21.7万 - 项目类别:
MESOLIMBIC DOPAMINE D3 RECEPTOR AND PARKINSON'S DISEASE
中脑边缘多巴胺 D3 受体与帕金森病
- 批准号:
6194137 - 财政年份:2000
- 资助金额:
$ 21.7万 - 项目类别:
MESOLIMBIC DOPAMINE D3 RECEPTOR AND PARKINSON'S DISEASE
中脑边缘多巴胺 D3 受体与帕金森病
- 批准号:
6540354 - 财政年份:2000
- 资助金额:
$ 21.7万 - 项目类别:
DEGENERATION OF DOPAMINERGIC PATHWAYS: PARKINSONS
多巴胺能通路退化:帕金森病
- 批准号:
6336901 - 财政年份:1998
- 资助金额:
$ 21.7万 - 项目类别:
DEGENERATION OF DOPAMINERGIC PATHWAYS: PARKINSONS
多巴胺能通路退化:帕金森病
- 批准号:
6251564 - 财政年份:1997
- 资助金额:
$ 21.7万 - 项目类别:
相似海外基金
Treating Agitation/Psychosis in Dementia/Parkinsonism
治疗痴呆/帕金森症的躁动/精神病
- 批准号:
6416122 - 财政年份:2002
- 资助金额:
$ 21.7万 - 项目类别:
Treating Agitation/Psychosis in Dementia/Parkinsonism
治疗痴呆/帕金森症的躁动/精神病
- 批准号:
6609763 - 财政年份:2002
- 资助金额:
$ 21.7万 - 项目类别:
異常蛋白質が引き起こす空胞形成の分子解析
异常蛋白质引起的空泡形成的分子分析
- 批准号:
14037232 - 财政年份:2002
- 资助金额:
$ 21.7万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Clinical and Basic Research of Dementia with Lewy bodies
路易体痴呆的临床与基础研究
- 批准号:
14370293 - 财政年份:2002
- 资助金额:
$ 21.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Dementia of Parkinson Type: Clinicopathologic Phenotype
帕金森型痴呆:临床病理表型
- 批准号:
6478018 - 财政年份:2002
- 资助金额:
$ 21.7万 - 项目类别: